HomeInsightsStock Comparison

Bharat Immunological Biological Corporation Ltd vs Sms Lifesciences India Ltd Stock Comparison

Bharat Immunological Biological Corporation Ltd vs Sms Lifesciences India Ltd Stock Comparison

Last Updated on: Dec 18, 2025

Key Highlights

  • The Latest Trading Price of Bharat Immunological & Biological Corporation Ltd is ₹ 18.83 as of 18 Dec 15:30.
  • The P/E Ratio of Bharat Immunological & Biological Corporation Ltd changed from 0 on March 2020 to 0 on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of SMS Lifesciences India Ltd changed from 5.2 on March 2020 to 16.2 on March 2025 . This represents a CAGR of 20.85% over 6 years.
  • The Market Cap of Bharat Immunological & Biological Corporation Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of SMS Lifesciences India Ltd changed from ₹ 52.91 crore on March 2020 to ₹ 326.64 crore on March 2025 . This represents a CAGR of 35.44% over 6 years.
  • The revenue of Bharat Immunological & Biological Corporation Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of SMS Lifesciences India Ltd for the Sep '25 is ₹ 81.79 crore as compare to the Jun '25 revenue of ₹ 83.5 crore. This represent the decline of -2.05%.
  • The ebitda of Bharat Immunological & Biological Corporation Ltd for the Sep '25 is ₹ 0 crore as compare to the Jun '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of SMS Lifesciences India Ltd for the Sep '25 is ₹ 13.99 crore as compare to the Jun '25 ebitda of ₹ 12.71 crore. This represent the growth of 10.07%.
  • The net profit of Bharat Immunological & Biological Corporation Ltd changed from ₹ 0 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of 0.0% The net profit of SMS Lifesciences India Ltd changed from ₹ -3.83 crore to ₹ 6.43 crore over 10 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Bharat Immunological & Biological Corporation Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of SMS Lifesciences India Ltd changed from 3.44 % on March 2021 to 2.12 % on March 2025 . This represents a CAGR of -9.23% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Bharat Immunological & Biological Corporation Ltd

  • The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology.
  • BIBCOL was incorporated in 1989.
  • The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets. The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh.
  • BIBCL installed a plant of 100 mln units.
  • Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme.

About SMS Lifesciences India Ltd

  • SMS Lifesciences India Limited was incorporated originally as 'Potluri Real Estate Private Limited' on May 31, 2006.
  • The Company's name was changed to 'Potluri Packaging Industries Private Limited' on 6 November, 2013 and again changed to 'SMS Lifesciences India Private Limited on 4 August, 2014 to undertake the activities related pharma sector.
  • The Company became a wholly owned subsidiary Company of SMS Pharmaceuticals Limited w.e.f. 01.04.2016 and subsequently got converted into a Public Limited w.e.f. 22 June, 2016. The Company is engaged in the business of manufacturing and export of Active Pharma Ingredients(APIs) and their intermediates.
  • The Company is having manufacturing facilities at Kazipally and Jeedimetla, Hyderabad with an installed capacity of 65 KL. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having products spread across an array of therapeutic segments.

Bharat Immunological & Biological Corporation Ltd News Hub

News

Bharat Immunological & Biological Corporation Ltd leads losers in 'B' group

Relicab Cable Manufacturing Ltd, Precision Wires India Ltd, Brainbees Solutions Ltd and Fl...

Read more

08 Jan 2025 14:45

News

Bharat Immunological & Biological Corporation Ltd leads gainers in 'B' group

Bodhi Tree Multimedia Ltd, Mangal Credit & Fincorp Ltd, Innovana Thinklabs Ltd and Bartron...

Read more

06 Jan 2025 12:15

News

Bharat Immunological & Biolog.Corp. to hold board meeting

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the C...

Read more

10 Aug 2024 17:28

News

Bharat Immunological & Biolog.Corp. announces board meeting date

Bharat Immunological & Biolog.Corp. will hold a meeting of the Board of Directors of the C...

Read more

01 Mar 2024 10:22

News

Bharat Immunological & Biolog.Corp. to convene AGM

Bharat Immunological & Biolog.Corp. announced that the 34th Annual General Meeting (AGM) o...

Read more

29 Nov 2023 10:47

News

Bharat Immunological & Biolog.Corp. to conduct AGM

Bharat Immunological & Biolog.Corp. announced that the 34th Annual General Meeting (AGM) o...

Read more

28 Nov 2023 18:37

SMS Lifesciences India Ltd News Hub

News

SMS LifeSciences India announces board meeting date

SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 10 ...

Read more

05 Nov 2025 16:14

News

SMS LifeSciences India AGM scheduled

SMS LifeSciences India announced that the 19th Annual General Meeting(AGM) of the company ...

Read more

29 Aug 2025 15:54

News

SMS LifeSciences India to table results

SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 11 ...

Read more

08 Aug 2025 12:44

News

SMS Lifesciences India Ltd leads gainers in 'B' group

Magellanic Cloud Ltd, Fischer Medical Ventures Ltd, Global Surfaces Ltd and 20 Microns Ltd...

Read more

16 Jul 2025 12:15

News

Board of SMS LifeSciences India recommends final dividend

SMS LifeSciences India announced that the Board of Directors of the Company at its meeting...

Read more

30 May 2025 11:19

News

SMS LifeSciences India to announce Quarterly Result

SMS LifeSciences India will hold a meeting of the Board of Directors of the Company on 29 ...

Read more

24 May 2025 11:21

SWOT Analysis Of Bharat Immunological & Biological Corporation Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of SMS Lifesciences India Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Bharat Immunological & Biological Corporation Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for SMS Lifesciences India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Bharat Immunological & Biological Corporation Ltd and SMS Lifesciences India Ltd

Which company has a larger market capitalization, Bharat Immunological & Biological Corporation Ltd or SMS Lifesciences India Ltd?

Market cap of Bharat Immunological & Biological Corporation Ltd is 81 Cr while Market cap of SMS Lifesciences India Ltd is 407 Cr

What are the key factors driving the stock performance of Bharat Immunological & Biological Corporation Ltd and SMS Lifesciences India Ltd?

The stock performance of Bharat Immunological & Biological Corporation Ltd and SMS Lifesciences India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bharat Immunological & Biological Corporation Ltd and SMS Lifesciences India Ltd?

As of December 18, 2025, the Bharat Immunological & Biological Corporation Ltd stock price is INR ₹18.81. On the other hand, SMS Lifesciences India Ltd stock price is INR ₹1349.0.

How do dividend payouts of Bharat Immunological & Biological Corporation Ltd and SMS Lifesciences India Ltd compare?

To compare the dividend payouts of Bharat Immunological & Biological Corporation Ltd and SMS Lifesciences India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions